Edition:
United States

Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

326.11USD
6 Dec 2016
Change (% chg)

$-16.14 (-4.72%)
Prev Close
$342.25
Open
$340.00
Day's High
$343.13
Day's Low
$326.11
Volume
1,257
Avg. Vol
798
52-wk High
$406.88
52-wk Low
$255.75

Select another date:

Fri, Nov 4 2016

CMS revokes Alere unit's Medicare enrollment

Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

CMS revokes Alere unit's Medicare enrollment

Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

UPDATE 2-CMS revokes Alere unit's Medicare enrollment

Nov 4 Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

REFILE-CMS to revoke Alere unit's Medicare enrollment

Nov 4 The Centers for Medicare and Medicaid Services (CMS) sent Alere Inc a notice on Oct. 5 saying it would revoke the Medicare enrollment of one of the molecular diagnostic company's unit, Alere said in a regulatory filing on Friday.

BRIEF-Alere's unit Arriva Medical receives notice that medicare enrollment will be revoked by CMS

* Alere - on oct 12, co's unit arriva medical received notice, dated oct 5, that medicare enrollment will be revoked by CMS - sec filing

BRIEF-Alere reports Q3 EPS $0.19 from continuing operations

* Q3 earnings per share view $0.54 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

CORRECTED-UPDATE 3-Abbott moves ahead on St. Jude, Alere deals, but investors fret

Oct 19 Abbott Laboratories said on Wednesday it was pushing ahead to complete its planned purchases of medical device maker St. Jude Medical Inc and diagnostics company Alere Inc despite lingering questions about product safety and government investigations.

BRIEF-China clears Abbott's acquisition of Alere

* People's Republic of China clears Abbott acquisition of Alere

Abbott moves ahead on St. Jude, Alere deals, but investors fret

Abbott Laboratories said on Wednesday it was pushing ahead to complete its planned purchases of medical device maker St. Jude Medical Inc and diagnostics company Alere Inc despite lingering questions about product safety and government investigations.

Abbott moves ahead on St. Jude, Alere deals, but investors fret

Abbott Laboratories said on Wednesday it was pushing ahead to complete its planned purchases of medical device maker St. Jude Medical Inc and diagnostics company Alere Inc despite lingering questions about product safety and government investigations.

Select another date: